Rhino Rounds International - Moving forward in CRSwNP
Rhino Rounds International where leading experts shared their insights and expertise in the latest advancements in CRSwNP. This event provided a unique opportunity to discuss with peers and gain a comprehensive understanding in the world of rhinology.
Watch the recording
The recording has been devided into chapters
Watch the different episodes of the webinar below:
Biologics
Professor Hellings
Type 2 inflammation
Professor Hellings
Burden of disease
Professor Hellings
Treatment options
Professor Hellings
Real World Evidence
Dr. Reitsma
Patient case 1
Dr. Reitsma
Patient case 2
Dr. Reitsma
Guidelines
Dr. Reitsma
Speakers
Peter Hellings
MD, PhD
Belgium
Peter W. Hellings is a Professor in Otorhinolaryngology at the Catholic University of Leuven, Belgium, and Clinic Head at the Department of Otorhinolaryngology at the University Hospitals of Leuven. He is also a former Professor at the University of Amsterdam, The Netherlands, and a Guest Professor at the University of Ghent, Belgium. Following his speciality training and doctoral thesis in 2001, he combined clinical work in the field of rhinoplasty and sinus surgery, with the guidance of several PhD fellows in research on airway immunology, allergology, sinus disease and rhinoplasty. His scientific work is published in over 275 scientific reports and has been awarded several international prizes. He is the course director of the European Rhinoplasty Course in Brussels and the International Course in Modern Rhinoplasty Techniques Amsterdam and the past-Secretary-General of EAACI (2015-2019). In 2015, he founded the non-profit organization EUFOREA aiming at arresting the epidemics of chronic respiratory diseases (CRD) in Europe via digital solutions and structural collaboration with relevant stakeholders in the field of CRD. At the occasion of the National Day in 2016, King Filip of Belgium granted him the title of Commander in the Order of Leopold.
Sietze Reitsma
MD, PhD
Netherlands
Dr. Reitsma is an ENT physician at the Amsterdam UMC and is a globally recognized leader in Chronic Rhinosinusitis with Nasal Polyposis and sinus and skull base surgery with more than 85 research publications. His expertise lies in understanding mucosal pathology in the upper and lower airways, with a particular focus on precision medicine. Dr. Reitsma's research encompasses diverse areas such as quality of life assessments, treatment outcomes, and economic considerations, aiming to improve patient care on individual and societal levels. A distinguishing aspect of Dr. Reitsma's work is his exploration of treatable traits and endotyping within CRSwNP. Through a combination of basic immunological research, epidemiological studies, and clinical trials, he seeks to uncover the underlying mechanisms of this condition and develop personalized treatment approaches.
Agenda
|
Vill du läsa mer om behandling med Dupixent®(dupilumab) för de olika indikationerna, klicka in på Fass.se
Inbjudan skickas till berörda medarbetare inom respiratoriska sjukdomar, öron-näsa-hals och allergologi med kopia till verksamhetschef. Produktinformation kommer att förekomma. Din e-postadress kommer endast att användas för information kring mötet. Mötet följer överenskommelsen om samverkansregler mellan den offentligt finansierade hälso- och sjukvården (Sveriges Kommuner och Regioner, SKR) och läkemedelsindustrin (Läkemedelsindustriföreningen, LIF). Sanofi står för kostnaderna för föredragshållarna. Deltagaren ansvarar för att arbetsgivarens godkännande för deltagandet är inhämtat.
